Free Trial

Charles Schwab (NYSE:SCHW) to Repurchase $20.00 billion in Shares

Charles Schwab logo with Finance background

Charles Schwab (NYSE:SCHW - Get Free Report) announced that its board has approved a share buyback program on Thursday, July 24th, RTT News reports. The company plans to buyback $20.00 billion in shares. This buyback authorization permits the financial services provider to buy up to 11.6% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's leadership believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. TD Securities lifted their target price on Charles Schwab from $95.00 to $113.00 and gave the stock a "buy" rating in a report on Tuesday, May 20th. Raymond James Financial reaffirmed an "outperform" rating and set a $99.00 target price on shares of Charles Schwab in a report on Friday, July 18th. William Blair downgraded Charles Schwab from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 3rd. Citigroup boosted their price target on Charles Schwab from $105.00 to $110.00 and gave the company a "buy" rating in a report on Monday. Finally, The Goldman Sachs Group raised Charles Schwab from a "neutral" rating to a "buy" rating and set a $100.00 price target for the company in a report on Friday, April 25th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $98.65.

Check Out Our Latest Report on Charles Schwab

Charles Schwab Trading Up 1.5%

NYSE SCHW traded up $1.39 on Thursday, reaching $96.54. 9,042,432 shares of the company were exchanged, compared to its average volume of 8,724,406. The business's fifty day moving average price is $90.17 and its 200 day moving average price is $82.64. The stock has a market capitalization of $175.41 billion, a P/E ratio of 25.95, a price-to-earnings-growth ratio of 0.91 and a beta of 0.93. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.53. Charles Schwab has a fifty-two week low of $61.15 and a fifty-two week high of $97.50.

Charles Schwab (NYSE:SCHW - Get Free Report) last released its quarterly earnings data on Friday, July 18th. The financial services provider reported $1.14 earnings per share for the quarter, topping analysts' consensus estimates of $1.10 by $0.04. Charles Schwab had a return on equity of 19.73% and a net margin of 33.68%. The company had revenue of $5.85 billion for the quarter, compared to analyst estimates of $5.64 billion. During the same quarter in the previous year, the company posted $0.73 earnings per share. The firm's revenue for the quarter was up 24.8% compared to the same quarter last year. Analysts forecast that Charles Schwab will post 4.22 earnings per share for the current year.

Charles Schwab Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 22nd. Stockholders of record on Friday, August 8th will be paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 1.12%. Charles Schwab's dividend payout ratio (DPR) is presently 29.03%.

Insiders Place Their Bets

In related news, insider Jonathan M. Craig sold 47,500 shares of the stock in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $88.46, for a total transaction of $4,201,850.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Paul V. Woolway sold 10,129 shares of the stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $90.01, for a total value of $911,711.29. Following the transaction, the insider directly owned 39,154 shares in the company, valued at approximately $3,524,251.54. The trade was a 20.55% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 116,313 shares of company stock worth $10,264,091. Corporate insiders own 6.30% of the company's stock.

About Charles Schwab

(Get Free Report)

The Charles Schwab Corporation, together with its subsidiaries, operates as a savings and loan holding company that provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services in the United States and internationally. The company operates in two segments, Investor Services and Advisor Services.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Charles Schwab Right Now?

Before you consider Charles Schwab, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Charles Schwab wasn't on the list.

While Charles Schwab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines